HPS Header Logo
DONATE NOW
HPS Header Logo
DONATE NOW

Pharma listens to the HPS story

Donna Appell, Executive Director and Founder of the HPS Network, delivered a presentation about Hermansky-Pudlak Syndrome and the HPS Network to the 2022 Corporate Meeting of the American Thoracic Society (ATS). The meeting is attended by representatives of the...

Monthly Virtual Events

Mark your calendars to join us monthly for our virtual events! The information on all upcoming meetings can be found on our virtual events page.  Links to all events are included in our member emails.  If you aren’t receiving them or want to become a member,...

Dysregulated Myosin in HPS lung fibroblasts

Subject: Dysregulated myosin in Hermansky-Pudlak syndrome lung fibroblasts is associated with increased cell motility – PubMed Researchers continue to study pulmonary fibrosis in the HPS population.  Myosin is a protein that has a role in muscle contraction....

EL-PFDD Meeting held on June 10, 2022

This meeting was held June 10, 2022 and brought together representatives of the FDA, pharma and other interested parties to listen to the needs of the HPS community. The report that will come from this meeting will be used by the FDA and pharma to help analyze the...

Special Strain of Mice to Study Human Disease

Research continues as shown by this article. A murine model(special strain of mice to study human disease) has been developed for the study of HPS pulmonary fibrosis. A different mode of putting Bleomycin ( a chemotherapeutic antibiotic) into the mice model was...